市場調査レポート

商品コード

1563125

持続グルコースモニタリングシステムの世界市場：製品・用途・エンドユーザー・地域別の予測 (～2032年)

Global Continuous Glucose Monitoring Systems Market Research Report Information by Product, By Application, By End User, by Region Forecast till 2032

出版日: 2024年08月10日
発行: Market Research Future
ページ情報: 英文 152 Pages
納期: 即納可能

価格

PDF & Excel (Single User License)

USD 4,950 710,671円

レポートPDF、Excelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Multi User License)

USD 5,950 854,241円

レポートPDF、Excelを同一企業内の最大15名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Enterprise License)

USD 7,250 1,040,882円

レポートPDF、Excelを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDF、Excelの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

持続グルコースモニタリングシステムの市場規模は、2023年の88億米ドル、2024年の100億米ドルから、予測期間中は12.34%のCAGRで推移し、2032年には258億米ドルの規模に成長すると予測されています。

持続グルコースモニタリングシステム市場の拡大を促進する注目すべき要因の1つは、世界の糖尿病有病率の上昇です。世界の罹患者の大幅な増加により、糖尿病は今やパンデミックの割合に達しています。The International Diabetes Federation (IDF) は、2021年には世界で5億3,700万人が糖尿病を患い、この数字は2030年には6億4,300万人に増加すると予測しています。同様に、IDFは、2021年には人口の11.6％にあたる3,840万人の米国人が糖尿病に罹患すると推計しています。約30万4,000人の子供とティーンエイジャーを含む約200万人の米国人が1型糖尿病です。糖尿病罹患率上昇の原因としては、人口の高齢化、食習慣の乱れ、不活発なライフスタイルなどが挙げられます。糖尿病人口の増加に伴い、効率的な糖尿病ケアソリューションの必要性が高まっています。

地域別インサイト

北米市場は最大のシェアを示しています。強固な技術インフラがその背景にあり、確立された規制枠組みが市場を牽引すると想定されています。

欧州は、糖尿病有病率の上昇とCGM技術の開発により、第2位の市場シェアを占めています。

アジア太平洋地域は2023年から2032年にかけて注目の割合で成長すると予測されています。これは、同地域における糖尿病有病率の増加と糖尿病管理に対する意識の高まりの結果です。

当レポートでは、世界の持続グルコースモニタリングシステムの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

促進要因
- 糖尿病の罹患率の増加
- 持続グルコースモニタリングシステムと患者教育の利点に関する個人の意識の高まり
- 高齢化人口の増加
抑制要因
- 持続グルコースモニタリングシステムの高コスト性
機会
- 技術の進歩と革新の進展

第5章市場要因分析

バリューチェーン分析
ポーターのファイブフォース分析
COVID-19が世界の持続グルコースモニタリングシステム市場に与える影響

第6章世界の持続グルコースモニタリングシステム市場：製品別)

概要
センサー
送信機・受信機

第7章世界の持続グルコースモニタリングシステム市場：用途別

概要
2型糖尿病
1型糖尿病
非糖尿病患者
- 減量
- ダイエット管理
- 健康・ウェルネス

第8章世界の持続グルコースモニタリングシステム市場：エンドユーザー別

概要
病院・クリニック
ホームケア
その他

第9章世界の持続グルコースモニタリングシステム市場：地域別

世界
北米
欧州
アジア太平洋
その他の地域

第10章競合情勢

市場シェア分析
競合ダッシュボード
公開企業の株式概要
比較分析：主要企業の財務動向
主な展開と成長戦略

第11章企業プロファイル

DEXCOM, INC
A. MENARINI DIAGNOSTICS SRL
SENSEONICS
MEDTRUM TECHNOLOGIES INC.
NEMAURA MEDICAL INC.
ULTRAHUMAN HEALTHCARE PVT LTD
MEDTRONIC
ONE DROP
ABBOTT LABORATORIES, INC.
SINOCARE
NUTRISENSE
SUPERSAPIENS
SIGNOS INC.
LEVELS
VERI
LUMEN
JANUARY.AI

第12章データの引用

図表

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD MILLION)
TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD MILLION)
TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019-2032 (USD MILLION)
TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019-2032 (USD MILLION)
TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019-2032 (USD MILLION)
TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 17 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 22 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 26 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 30 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 35 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 39 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 43 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 47 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 51 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 55 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 59 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 64 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 68 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 72 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 76 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 80 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 84 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 88 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 89 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 93 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 97 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 101 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD MILLION)
TABLE 102 PUBLIC PLAYERS STOCK SUMMARY
TABLE 103 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 104 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 105 AGREEMENT
TABLE 106 PERTNERSHIP
TABLE 107 COLLABORATION
TABLE 108 DEXCOM, INC: PRODUCT OFFERED
TABLE 109 DEXCOM, INC: KEY DEVELOPMENTS
TABLE 110 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED
TABLE 111 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS
TABLE 112 SENSEONICS: PRODUCT OFFERED
TABLE 113 SENSEONICS: KEY DEVELOPMENTS
TABLE 114 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED
TABLE 115 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 116 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS
TABLE 117 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED
TABLE 118 MEDTRONIC: PRODUCTS OFFERED
TABLE 119 MEDTRONIC: KEY DEVELOPMENTS
TABLE 120 ONE DROP: PRODUCTS OFFERED
TABLE 121 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 122 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS
TABLE 123 SINOCARE: PRODUCTS OFFERED
TABLE 124 NUTRISENSE: PRODUCTS OFFERED
TABLE 125 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 126 SIGNOS INC.: PRODUCTS OFFERED
TABLE 127 LEVELS: PRODUCTS OFFERED
TABLE 128 VERI: PRODUCTS OFFERED
TABLE 129 LUMEN: PRODUCTS OFFERED
TABLE 130 JANUARY.AI: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE
FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT,
FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION,
FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER,
FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY,
FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION,
FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS,
FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 DEXCOM, INC: SWOT ANALYSIS
FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS
FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MEDTRONIC: SWOT ANALYSIS
FIGURE 32 ONE DROP: SWOT ANALYSIS
FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS LIST OF FIGURES
FIGURE 1 GLOBAL DIGITAL HEALTH MARKET: STRUCTURE
FIGURE 2 GLOBAL DIGITAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL DIGITAL HEALTH MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DIGITAL HEALTH MARKET
FIGURE 7 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)
FIGURE 8 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
FIGURE 9 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY TECHNOLOGY,
FIGURE 10 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)
FIGURE 11 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, 2023 & 2032 (USD MILLION)
FIGURE 12 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY COMPONENT,
FIGURE 13 GLOBAL DIGITAL HEALTH MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 14 GLOBAL DIGITAL HEALTH MARKET, END USER SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 15 GLOBAL DIGITAL HEALTH MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY END USER,
FIGURE 17 GLOBAL DIGITAL HEALTH MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 18 GLOBAL DIGITAL HEALTH MARKET, BY REGION, 2023 AND 2032 (USD MILLION)
FIGURE 19 NORTH AMERICA MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 20 NORTH AMERICA: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 21 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 & 20232 (USD MILLION)
FIGURE 22 EUROPE MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 23 EUROPE: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 24 EUROPE: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 25 ASIA-PAIFIC MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 26 ASIA-PAIFIC: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 27 ASIA-PAIFIC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 28 REST OF THE WORLD MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 29 REST OF THE WORLD: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 30 REST OF THE WORLD: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 31 GLOBAL DIGITAL HEALTH MARKET PLAYERS: COMPETITIVE ANALSIS,
FIGURE 32 COMPETITOR DASHBOARD: GLOBAL DIGITAL HEALTH MARKET
FIGURE 33 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ATHENAHEALTH: SWOT ANALYSIS
FIGURE 35 CISCO SYSTEMS, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 EPIC SYSTEMS CORPORATION: SWOT ANALYSIS
FIGURE 37 NXGN MANAGEMENT, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 NXGN MANAGEMENT, LLC: SWOT ANALYSIS
FIGURE 39 MCKESSON CORPORATION: FINANCIAL OVERVIEW
FIGURE 40 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
FIGURE 41 GENERAL ELECTRIC COMPANY: FINANCIAL OVERVIEW
FIGURE 42 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
FIGURE 43 VERADIGM, LLC: FINANCIAL OVERVIEW SNAPSHOT

Product Code: MRFR/HC/18762-CR

Global Continuous Glucose Monitoring Systems Market Research Report Information by Product (Sensors, And Transmitter and Receivers), By Application (Type 2, Type 1, Non-diabetic Patients), By End User (Hospitals & Clinics, Homecare Settings, And Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

Market Outlook

USD 8.8 billion in continuous glucose monitoring systems market value in 2023 With a compound annual growth rate (CAGR) of 12.34% for the forecast period (2024 - 2032), the market for Continuous Glucose Monitoring Systems is expected to rise from USD 10.0 Billion in 2024 to USD 25.8 billion by 2032.

One very notable factor driving the expansion of the Continuous Glucose Monitoring Systems Market is the rising global diabetes prevalence. With an amazing global increase in affected individuals, diabetes now reaches pandemic proportions. The International Diabetes Federation (IDF) estimates that 537 million people globally will be living with diabetes in 2021 and that figure is predicted to rise to 643 million by 2030. Likewise, the American Diabetes Association estimates that in 2021 diabetes will afflict 38.4 million Americans, or 11.6% of the population. About 2.0 million Americans, including some 304,000 children and teenagers, have type 1 diabetes. Among the several causes of the rising diabetes incidence include aging population, poor eating habits, and inactive lifestyles. The need of efficient diabetes care solutions gets more urgent as the diabetic population keeps rising.

Insights about Market Segments

Based on product, the segmentation of the Continuous Glucose Monitoring Systems Market divides sensors and transmitter and receivers.

Application that comprises type 2 diabetes, type 1 diabetes, and non-diabetic patients forms the basis of the market segmentation.

End users ranging from hospitals and clinics to homecare environments and others form the basis of the market segmentation.

Regional Insights

The report groups the market by Region: North America, Europe, Asia-Pacific, and the Rest of the World. America North-West With a market share of the highest 2023 constant glucose monitoring systems The strong technological infrastructure is the reason behind this; so, it is envisaged that the market would be driven by a well-established regulatory framework.

Thanks to rising diabetes prevalence in Europe and developments in CGM technology, Europe Continuous Glucose Monitoring Systems market holds second-largest market share. Furthermore, the Rest of Europe Continuous Glucose Monitoring Systems market is predicted to fastest-growing market in the European area while France Continuous Glucose Monitoring Systems market was ascribed to hold the highest market share.

From 2023 to 2032, the Asia-Pacific Continuous Glucose Monitoring Systems market is predicted to expand at a noteworthy proportion. This is a result of growing diabetes prevalence in the area and growing consciousness of diabetes control. Furthermore projected to have the biggest market share is China Continuous Glucose Monitoring Systems market; India Market for Continuous Glucose Monitoring Systems is predicted to develop fastest among Asia-Pacific countries.

The Middle East and Africa plus Latin America comprise the Rest of the World. Rising diabetes prevalence along with growing awareness of advanced glucose monitoring systems would probably cause the market for Continuous Glucose Monitoring Systems in the above stated areas to rise.

Leading Players

Key Companies in the Continuous Glucose Monitoring Systems Market are Dexcom, Inc. (US), Menarini Diagnostics SRL (Italy), Sensonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc. (US), Ultrahuman Healthcare Pvt LTD (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), Sinocare (China).

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF DIABETES
- 4.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION
- 4.2.3 INCREASING GERIATRIC POPULATION
4.3 RESTRAINTS
- 4.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS
4.4 OPPORTUNITY
- 4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION AND SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
- 5.3.1 OVERVIEW

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 SENSORS
6.3 TRANSMITTER & RECEIVERS

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 TYPE 2 DIABETES
7.3 TYPE 1 DIABETES
7.4 NON-DIABETIC PATIENTS
- 7.4.1 WEIGHT LOSS
- 7.4.2 DIET MANAGEMENT
- 7.4.3 HEALTH & WELLNESS

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS & CLINICS
8.3 HOMECARE SETTINGS
8.4 OTHERS

9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

9.1 GLOBAL
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 INDIA
- 9.4.3 JAPAN
- 9.4.4 SOUTH KOREA
- 9.4.5 AUSTRALIA
- 9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST & AFRICA
- 9.5.2 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS,
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
- 10.6.2 AGREEMENT
- 10.6.3 PARTNERSHIP
- 10.6.4 COLLABORATION

11 COMPANY PROFILES

11.1 DEXCOM, INC
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 A. MENARINI DIAGNOSTICS SRL
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 KEY STRATEGIES
11.3 SENSEONICS
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 KEY STRATEGIES
11.4 MEDTRUM TECHNOLOGIES INC.
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
11.5 NEMAURA MEDICAL INC.
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
11.6 ULTRAHUMAN HEALTHCARE PVT LTD
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 KEY STRATEGIES
11.7 MEDTRONIC
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 ONE DROP
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 ABBOTT LABORATORIES, INC.
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 SWOT ANALYSIS
- 11.9.6 KEY STRATEGIES
11.10 SINOCARE
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES
11.11 NUTRISENSE
- 11.11.1 COMPANY OVERVIEW
- 11.11.2 FINANCIAL OVERVIEW
- 11.11.3 PRODUCTS OFFERED
- 11.11.4 KEY DEVELOPMENTS
- 11.11.5 KEY STRATEGIES
11.12 SUPERSAPIENS
- 11.12.1 COMPANY OVERVIEW
- 11.12.2 FINANCIAL OVERVIEW
- 11.12.3 PRODUCTS OFFERED
- 11.12.4 KEY DEVELOPMENTS
- 11.12.5 KEY STRATEGIES
11.13 SIGNOS INC.
- 11.13.1 COMPANY OVERVIEW
- 11.13.2 FINANCIAL OVERVIEW
- 11.13.3 PRODUCTS OFFERED
- 11.13.4 KEY DEVELOPMENTS
- 11.13.5 KEY STRATEGIES
11.14 LEVELS
- 11.14.1 COMPANY OVERVIEW
- 11.14.2 FINANCIAL OVERVIEW
- 11.14.3 PRODUCTS OFFERED
- 11.14.4 KEY DEVELOPMENTS
- 11.14.5 KEY STRATEGIES
11.15 VERI
- 11.15.1 COMPANY OVERVIEW
- 11.15.2 FINANCIAL OVERVIEW
- 11.15.3 PRODUCTS OFFERED
- 11.15.4 KEY DEVELOPMENTS
- 11.15.5 KEY STRATEGIES
11.16 LUMEN
- 11.16.1 COMPANY OVERVIEW
- 11.16.2 FINANCIAL OVERVIEW
- 11.16.3 PRODUCTS OFFERED
- 11.16.4 KEY DEVELOPMENTS
- 11.16.5 KEY STRATEGIES
11.17 JANUARY.AI
- 11.17.1 COMPANY OVERVIEW
- 11.17.2 FINANCIAL OVERVIEW
- 11.17.3 PRODUCTS OFFERED
- 11.17.4 KEY DEVELOPMENTS
- 11.17.5 KEY STRATEGIES

持続グルコースモニタリングシステムの世界市場：製品・用途・エンドユーザー・地域別の予測 (～2032年)

Global Continuous Glucose Monitoring Systems Market Research Report Information by Product, By Application, By End User, by Region Forecast till 2032

目次

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章世界の持続グルコースモニタリングシステム市場：製品別)

第7章世界の持続グルコースモニタリングシステム市場：用途別

第8章世界の持続グルコースモニタリングシステム市場：エンドユーザー別

第9章世界の持続グルコースモニタリングシステム市場：地域別

第10章競合情勢

第11章企業プロファイル

第12章データの引用

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

12 DATA CITATIONS

持続グルコースモニタリングシステムの世界市場：製品・用途・エンドユーザー・地域別の予測 (～2032年)

Global Continuous Glucose Monitoring Systems Market Research Report Information by Product, By Application, By End User, by Region Forecast till 2032

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

第5章 市場要因分析

第6章 世界の持続グルコースモニタリングシステム市場：製品別)

第7章 世界の持続グルコースモニタリングシステム市場：用途別

第8章 世界の持続グルコースモニタリングシステム市場：エンドユーザー別

第9章 世界の持続グルコースモニタリングシステム市場：地域別

第10章 競合情勢

第11章 企業プロファイル

第12章 データの引用

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

12 DATA CITATIONS

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章世界の持続グルコースモニタリングシステム市場：製品別)

第7章世界の持続グルコースモニタリングシステム市場：用途別

第8章世界の持続グルコースモニタリングシステム市場：エンドユーザー別

第9章世界の持続グルコースモニタリングシステム市場：地域別

第10章競合情勢

第11章企業プロファイル

第12章データの引用